<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01987024</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00780-45</org_study_id>
    <secondary_id>2013-21</secondary_id>
    <nct_id>NCT01987024</nct_id>
  </id_info>
  <brief_title>Advantage of Detection of phIGFBP-1 to Reduce Hospitalization Time for Stable Patients With a Risk of Preterm Labour.</brief_title>
  <official_title>Advantage of Detection of phIGFBP-1 to Reduce Hospitalization Time for Stable Patients With a Risk of Preterm Labour.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It consists of evaluating the advantage of routine detection of phIGFBP-1 to reduce the total&#xD;
      duration of hospitalization for patients with a risk of preterm labor before 32 weeks of&#xD;
      gestation without increasing the number of preterm labour.&#xD;
&#xD;
      Methods Patient with a risk of preterm labor (ultrasound cervical length &lt; 25 mm +/-&#xD;
      described or recorded uterine contractions) before 32 weeks of gestation will be hospitalized&#xD;
      to receive tocolytic drugs and antenatal corticosteroid therapy according to our gold&#xD;
      standard protocol. After 48 hours, they will be assessed by examination, external&#xD;
      tocodynamometry and the measure of cervical length by ultrasound. Stabilized patients will be&#xD;
      included and randomized into 2 groups of 210 patients each. The first group &quot;A&quot; will benefit&#xD;
      from the standard protocol (extended hospitalization of 2 or 4 days according to the clinical&#xD;
      and ultrasound assessment); whereas the second group, &quot;B&quot;, will have the benefit of the&#xD;
      detection of phIGFBP-1.If the result proves negative, patients could be discharged early at&#xD;
      day 2. In the case of a positive result, patients will follow the standard procedure because&#xD;
      of the low positive predictive value of the test. The main outcome is the total duration of&#xD;
      hospitalization.&#xD;
&#xD;
      Study duration The trial period will be 36 months.&#xD;
&#xD;
      Expected results The use of detection of IGFBP-1 would enable us to select patients at risk&#xD;
      and to decrease the duration of hospitalization in the case of a negative result.&#xD;
&#xD;
      Perspectives The negative predictive value of phIGFBP-1 test could be useful to select&#xD;
      patients with stabilized risk of preterm labor, who could be discharged early. Moreover it&#xD;
      could be used, in the Perinat Sud network, to decide if patients with a risk of preterm labor&#xD;
      would benefit from hospitalization in a level II or III maternity ward.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">March 16, 2020</completion_date>
  <primary_completion_date type="Actual">September 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>vaginal cervical sampling</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">272</enrollment>
  <condition>Patients With a Risk of Preterm Labour</condition>
  <arm_group>
    <arm_group_label>group A-usual procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>groupB- actim partus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Actim Partus® test</intervention_name>
    <arm_group_label>groupB- actim partus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual procedure</intervention_name>
    <arm_group_label>group A-usual procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Women aged 18 years or more,&#xD;
&#xD;
               -  Women with a single intrauterine pregnancy with a term consistent with the LMP&#xD;
                  and / or ultrasound of the first quarter,&#xD;
&#xD;
               -  Women with a pregnancy in which the term is greater than 24 weeks and strictly&#xD;
                  less than 34 weeks,&#xD;
&#xD;
               -  initially consultant Woman (D0):&#xD;
&#xD;
          -  For painful uterine contractions associated with ultrasound measurement of a neck (LC)&#xD;
             of less than 25 mm,&#xD;
&#xD;
          -  Or cervical changes discovered incidentally during a vaginal examination confirmed by&#xD;
             LC &lt;25 mm,&#xD;
&#xD;
          -  Or during a routine ultrasound with LC &lt;25 mm;&#xD;
&#xD;
          -  Patient with a MAP stabilized in terms Clinical Ultrasound in D2:&#xD;
&#xD;
        Clinical criteria: absence of painful uterine contractions described or strictly less than&#xD;
        3 uterine contractions recorded during an external électrocardiotocographie for 30 minutes;&#xD;
        And sonographic criteria: cervicométrie measured steady J2 (+ / - 10%) or increased&#xD;
        relative to the cervicométrie J0.&#xD;
&#xD;
        - Women who have signed a written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Minor Female,&#xD;
&#xD;
          -  Women with a multiple pregnancy,&#xD;
&#xD;
          -  Women with a pathological whose late intrauterine growth preeclampsia, fetal&#xD;
             malformations, maternal-fetal immunizations, abnormal amount of amniotic fluid&#xD;
             (polyhydramnios / oligohydramnios), abnormal insertion of pregnancy placenta (low&#xD;
             inserted / previa acreta / percreta)&#xD;
&#xD;
          -  Women with pregnancy circled,&#xD;
&#xD;
          -  Women with premature rupture of membranes or signs of chorioamnionitis,&#xD;
&#xD;
          -  Women with bleeding irregularities,&#xD;
&#xD;
          -  Women with uterine malformation (septate uterus, bicornuate, polyfibromateux)&#xD;
&#xD;
          -  Women are not affiliated with the social security system,&#xD;
&#xD;
          -  Women who can not receive an informed information&#xD;
&#xD;
          -  Women who have not signed the informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LOIC MONDOLONI</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13354</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 16, 2013</study_first_submitted>
  <study_first_submitted_qc>November 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2013</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

